Topic · Oncology
Clusterin in disease pathology
Clusterin in disease pathology is a research topic within Oncology. Science Explorer counts 4.8k research works in it since 1954. 10.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the multifaceted role of Clusterin, a chaperone protein, in cancer development, progression, and therapy. It investigates its involvement in apoptosis inhibition, TGF-ß signaling modulation, angiogenesis promotion, chemoresistance, and its potential as a biomarker for various cancers. The papers also discuss the implications of Clusterin in metastasis, particularly in prostate cancer.
- Clusterin
- Chaperone
- Apoptosis
- Cancer
- Metastasis
- TGF-ß Signaling
- Angiogenesis
- Prostate Cancer
- Chemoresistance
- Biomarker
- Research works
- 4.8k fractional, since 1954
- In the world top 10%
- 486 per year above
- Top-10% rate
- 10.2% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +69% the tick is no change
- Largest producer
China
64% of the 10 largest, 2022-now
Drawing this view